Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (121-130 of 508) with videos related to

Pageof 51
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 12, 2012
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT studyMichael Böhm, Jeffrey Borer, Ian Ford, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2005
Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery diseaseSammy Al-Benna, Carlene A Hamilton, John D McClure, et al.
ESC Heart Failure|October 9, 2019
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.mNadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, et al.
Journal of Clinical Lipidology|February 10, 2018
Visit-to-visit lipid variability: Clinical significance, effects of lipid-lowering treatment, and (pharmaco) geneticsRoelof A J Smit, Johan Wouter Jukema, Iris Postmus, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trialDavid Preiss, Suzanne M Lloyd, Ian Ford, et al.
European Journal of Heart Failure|February 8, 2014
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFTAdriaan A Voors, Dirk J van Veldhuisen, Michele Robertson, et al.
European Journal of Heart Failure|March 6, 2013
Risk following hospitalization in stable chronic systolic heart failurePutte Abrahamsson, Karl Swedberg, Jeffrey S Borer, et al.
Journal of Hypertension|December 17, 2009
Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDOHari K Parthasarathy, Khamis Alhashmi, Alex D McMahon, et al.
Lancet (London, England)|January 16, 2007
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control studyScott W Brouilette, Jasbir S Moore, Alex D McMahon, et al.
JAMA Internal Medicine|August 14, 2013
Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trialMiles D Witham, Rosemary J G Price, Allan D Struthers, et al.
Pageof 51

Showing results (121-130 of 508) with videos related to

Sort By:
Pageof 51
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 12, 2012
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT studyMichael Böhm, Jeffrey Borer, Ian Ford, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2005
Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery diseaseSammy Al-Benna, Carlene A Hamilton, John D McClure, et al.
ESC Heart Failure|October 9, 2019
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.mNadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, et al.
Journal of Clinical Lipidology|February 10, 2018
Visit-to-visit lipid variability: Clinical significance, effects of lipid-lowering treatment, and (pharmaco) geneticsRoelof A J Smit, Johan Wouter Jukema, Iris Postmus, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trialDavid Preiss, Suzanne M Lloyd, Ian Ford, et al.
European Journal of Heart Failure|February 8, 2014
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFTAdriaan A Voors, Dirk J van Veldhuisen, Michele Robertson, et al.
European Journal of Heart Failure|March 6, 2013
Risk following hospitalization in stable chronic systolic heart failurePutte Abrahamsson, Karl Swedberg, Jeffrey S Borer, et al.
Journal of Hypertension|December 17, 2009
Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDOHari K Parthasarathy, Khamis Alhashmi, Alex D McMahon, et al.
Lancet (London, England)|January 16, 2007
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control studyScott W Brouilette, Jasbir S Moore, Alex D McMahon, et al.
JAMA Internal Medicine|August 14, 2013
Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trialMiles D Witham, Rosemary J G Price, Allan D Struthers, et al.
Pageof 51